Associate Professor Francisco Marin

Back

Associate Professor Francisco Marin

Virgen of the Arrixaca University Hospital, Murcia (Spain)

Member of:

Presentations Articles

There is a role for anticoagulation in patients with HFrEF in sinus rhythm: pro

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session: Great Debate: controversies in the contemporary management of HFrEF

Access

Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Clinical

Session: Atrial fibrillation e-posters

Access

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Insights from acute coronary syndrome registries

Access

Arrhythmia management and device therapies in endocrine disorders

Event: EHRA 2019

Topic: Pathophysiology and Mechanisms

Session: EHRA expert consensus papers - Key messages 4

Access

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

Event: ESC Congress 2017

Topic: Biomarkers

Session: Outcomes in atrial fibrillation: room for improvement?

Access

Dealing with left atrial appendage clot

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Access

The influence of obesity and sleep apnea on atrial fibrillation

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Preventing and delaying atrial fibrillation

Access

Galentin 3 as marker of interstitial atrial remodeling involved in atrial fibrillation

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Access

Management of acute coronary syndrome in the elderly: comparison of antiplatelet treatment, revascularization rates and outcome

Event: ESC Congress 2016

Topic: Elderly and cardiovascular diseases

Session: Are we better at managing cardiovascular disease in the elderly?

Access

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation II

Access

ESC 365 is supported by

Explore sponsored resources

Associate Professor Francisco Marin Follow

Contributor content

There is a role for anticoagulation in patients with HFrEF in sinus rhythm: pro

Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy

Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.

Arrhythmia management and device therapies in endocrine disorders

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

Dealing with left atrial appendage clot

The influence of obesity and sleep apnea on atrial fibrillation

Galentin 3 as marker of interstitial atrial remodeling involved in atrial fibrillation

Management of acute coronary syndrome in the elderly: comparison of antiplatelet treatment, revascularization rates and outcome

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) biomarker substudy

ESC 365 is supported by

Associate Professor Francisco Marin